Leopoldo is an independent strategic advisor in the Life Science sector.
In this capacity he has advised various companies on Merger and Acquisitions, out-licensing deals and financing strategy, including advising Nogra Pharma in the largest ever out licensing to Celgene for a compound in development.
Prior to becoming an independent advisor he was a Senior Managing Director and Head of European, India and MENA Healthcare Investment Banking at Credit Suisse and the Head of the Ultra High Net Worth group from 2007 to 2012.
From 1994 to 2007, he held various positions at J.P. Morgan, including Head of Healthcare Investment Banking as a Managing Director.
He servesas a member of the board of directors of Nogra Pharma, Summit Therapeutics, Advanced Accelerator Applications and Qardio. He is also a trustee of Barts and the London Charity, the NHS largest Trust and a founder of the cultural initiative 5×15 Italy.
Leopoldo received bachelor’s degree in business administration from the Università Commerciale Luigi Bocconi in Milan, Italy.
